Isto Biologics
PrivateLast Round
Buyout/LBO
Sep 17, 2025
Est. Valuation
$1B
Total Funding Raised
$37.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Isto Biologics is a biotechnology company that manufactures orthobiologic medical devices, including autologous concentration systems, allografts, and biosynthetic bone grafts, for use in spine, orthopedics, and sports medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isto Biologics Comparables
Compare Isto Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Royal Biologics | 79% | |
| Xtant Medical Holdings | 79% | |
| VIVEX Biologics | 78% |
Isto Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Sep 17, 2025 | ||||
| M&A | Oct 25, 2023 | ||||
| Buyout/LBO | Jun 3, 2016 | ||||
| Debt | Mar 18, 2014 | ||||
| Growth Equity | Oct 25, 2007 | ||||
Series E | Aug 1, 2007 |
Isto Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DW Healthcare Partners | Growth Equity |
| EQT Life Sciences | Series E, Series D |
| Mid-America Transplant Services | Series E, Series D |
| Thompson Street Capital Partners | Buyout/LBO, M&A |
| Keensight Capital | Buyout/LBO |
| Alafi Capital | Series E, Series D |
| Ascension Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 43, 331% of headcount.
- Sep 17, 2025
$1.0B round led by Keensight Capital
Recent news
Latest coverage and updates
- acquiresAug 4, 2026
Isto Biologics acquired NovaBone Products, LLC for $60.7M on Aug 4th '26.
Isto Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access